Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02502929 · ClinicalTrials.gov registry record · NA
Diabetes Risk Reduction Through Eat, Walk, Sleep and Medication Therapy Management for Depressed Cambodians
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 182
- Enrollment target
NCT02502929 is a NA study that has completed, run by UConn Health. The registered enrollment target is 182 participants.
The verdict
NCT02502929, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
Study Summary
The primary aim of the study is to compare the effect of three different interventions on lifestyle risk factors and biological risk factors for type 2 diabetes in depressed Cambodians. The three different interventions are lifestyle, lifestyle plus medication therapy management, and social services.
Interventions
- BEHAVIORAL Lifestyle
- BEHAVIORAL Social Services
- BEHAVIORAL Lifestyle Plus Medication Therapy Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2015-11 |
| Est. Completion | 2020-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02502929
The ClinicalTrials.gov registry entry for NCT02502929 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Lifestyle is the first listed.
NCT02502929 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02502929 about?
NCT02502929 is a clinical study titled "Diabetes Risk Reduction Through Eat, Walk, Sleep and Medication Therapy Management for Depressed Cambodians". The primary aim of the study is to compare the effect of three different interventions on lifestyle risk factors and biological risk factors for type 2 diabetes in depressed Cambodians. The three different interventions are lifestyle, lifestyle plus medication therapy management, and social services...
What is the current status of trial NCT02502929?
This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2015-11. Estimated completion is 2020-09.
What interventions are being tested in trial NCT02502929?
The interventions under investigation include: Lifestyle (BEHAVIORAL), Social Services (BEHAVIORAL), Lifestyle Plus Medication Therapy Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT02502929?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.